Cover Image
市場調查報告書

核子醫學攝影系統及設備的全球市場 2021年:各產品(單光子發射電腦斷層掃描(SPECT),混合正子發射斷層掃描(PET),Planar Scintigraphy),用途及各終端用戶分析

Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, Planar Scintigraphy), Application (Oncology, Cardiology & Neurology), End user (Hospitals, Imaging Centers) - Global Forecasts to 2021

出版商 MarketsandMarkets 商品編碼 229380
出版日期 內容資訊 英文 169 Pages
訂單完成後即時交付
價格
Back to Top
核子醫學攝影系統及設備的全球市場 2021年:各產品(單光子發射電腦斷層掃描(SPECT),混合正子發射斷層掃描(PET),Planar Scintigraphy),用途及各終端用戶分析 Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, Planar Scintigraphy), Application (Oncology, Cardiology & Neurology), End user (Hospitals, Imaging Centers) - Global Forecasts to 2021
出版日期: 2017年01月06日 內容資訊: 英文 169 Pages
簡介

全球核子醫學攝影系統及設備市場,預計2016年達到22億5,000萬美元,此後5年以年複合成長率4.8%的規模成長,2021年達到28億5,000萬美元。

本報告提供核子醫學攝影系統的全球市場相關調查分析,相關產品開發、服務提供的主要企業的策略和促進市場成長的要素,阻礙因素等資料彙整,並將其結果為您概述為以下內容。

目錄

第1章 簡介

  • 調查的目的
  • 市場定義
  • 調查對象市場
  • 貨幣
  • 單位
  • 利害關係者
  • 調查的限制

第2章 調查方法

第3章 摘要整理

第4章 重要考察

第5章 市場概況

  • 簡介
  • 市場動態
    • 成長推動因素
    • 阻礙因素
    • 機會
    • 課題

第6章 產業分析

  • 波特的五力分析

第7章 各產品市場

  • 簡介
  • SPECT
    • 混合SPECT
    • 自主型SPECT
  • 混合PET技術
  • Planar Scintigraphy

第8章 各用途市場

  • 簡介
  • 腫瘤學
  • 心臟學
  • 神經學
  • 其他的用途

第9章 各終端用戶市場

  • 簡介
  • 醫院
  • 影像中心
  • 學術、研究中心
  • 其他用戶

第10章 各地區分析

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第11章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形及趨勢

第12章 企業簡介(概要,產品與服務,財務,策略、發展趨勢)

  • 簡介
  • SIEMENS AG (SIEMENS HEALTHINEERS)
  • GE HEALTHCARE (A FULLY OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
  • PHILIPS HEALTHCARE
  • DIGIRAD CORPORATION
  • NEUSOFT MEDICAL SYSTEMS CO., LTD.
  • 東芝MedicalSystems(佳能的子公司)
  • SURGICEYE GMBH
  • DDD-DIAGNOSTIC A/S
  • CMR NAVISCAN CORPORATION
  • MEDISO MEDICAL IMAGING SYSTEMS LTD.

第13章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 1010

The nuclear imaging equipment market is projected to reach USD 2.85 billion by 2021 from USD 2.25 billion in 2016, growing at a CAGR of 4.8% in the next five years (2016 to 2021). Over the years, the nuclear imaging equipment market has witnessed various advancements. The market is in its growth phase with increasing focus on improving the previous technology and introducing new products.

Factors such as introduction of new and advanced products, investment for the modernization of diagnostic imaging centers, development of new radiotracers, increasing incidence of cancer & cardiovascular diseases, and product launches by industry players are expected to drive the nuclear imaging equipment market in the coming years.

In 2016, North America is expected to account for the largest share of the global nuclear imaging equipment market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is projected to have the highest growth rate in the forecast period. Factors such as increasing incidence/prevalence of various diseases (such as cancer and CVDs), increasing government initiatives for the modernization of healthcare infrastructure, and increasing focus of the market players are likely to propel the market in the Asia-Pacific region.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies to increase their market shares and establish a strong foothold in the global market.

In-depth interviews were conducted with CEOs, sales and marketing directors, other innovation and technology directors, and executives from various key organizations operating in the nuclear imaging equipment market.

  • By Company Type: Tier 1: 32%, Tier 2: 39%, and Tier 3: 29%
  • By Designation: Director Level: 38%, C-level: 28%, and Others: 34%
  • By Region: North America: 30%, Europe: 27%, APAC: 33%, and RoW: 10%

The major players in the global nuclear imaging equipment market are Siemens Healthineers (Germany), Philips Healthcare (Netherlands), and GE Healthcare (U.S.). The other players in the market include Toshiba Medical Systems Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Digirad Corporation (U.S.), CMR Naviscan Corporation (U.S.), SurgicEye GmbH (Germany), and DDD Diagnostics (Denmark).

Research Coverage:

The report provides detailed description of the imaging systems used in diagnostics across various regions. It aims at estimating the market size and future growth potential of this market across different segments such as product, application, end user, and region. Additionally, the report includes an in-depth competitive analysis of the key players in the market along with their company profiles, SWOT analysis, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the products and services offered by top players in the nuclear imaging equipment market. The report analyzes the nuclear imaging equipment market by product, application, end user, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the nuclear imaging equipment market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for nuclear imaging equipment across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the nuclear imaging equipment market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and distribution networks of the leading players in the nuclear imaging equipment market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. PERIOD CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY CONSIDERED FOR THE STUDY
  • 1.5. UNIT CONSIDERED FOR THE STUDY
  • 1.6. STAKEHOLDERS
  • 1.7. LIMITATIONS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key insights from primary sources
      • 2.2.2.3. Key industry insights
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. NUCLEAR IMAGING EQUIPMENT MARKET OVERVIEW
  • 4.2. NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION AND END USER
  • 4.3. GEOGRAPHICAL SNAPSHOT OF THE NUCLEAR IMAGING EQUIPMENT MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Shift from standalone to hybrid modalities
      • 5.2.1.2. Advances in radiotracers
      • 5.2.1.3. Increasing focus on personalized medicine to boost the nuclear imaging market growth
      • 5.2.1.4. Investments through public-private partnerships to modernize diagnostic imaging centers
      • 5.2.1.5. Increasing incidences and prevalence of cancer and cardiac ailments
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Shorter half-life of radiopharmaceuticals
      • 5.2.2.2. Global shortage of Tc-99m
      • 5.2.2.3. High cost of nuclear imaging equipment
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growing demand for data integrated imaging systems
      • 5.2.3.2. High demand in emerging markets
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Increased adoption of refurbished diagnostic systems
      • 5.2.4.2. Hospital budget cuts

6. INDUSTRY INSIGHTS

  • 6.1. PORTER'S FIVE FORCES ANALYSIS
    • 6.1.1. BARGAINING POWER OF BUYERS
    • 6.1.2. BARGAINING POWER OF SUPPLIERS
    • 6.1.3. THREAT FROM NEW ENTRANTS
    • 6.1.4. THREAT OF SUBSTITUTES
    • 6.1.5. INTENSITY OF COMPETITIVE RIVALRY

7. NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. SINGLE PHOTON-EMISSION COMPUTED TOMOGRAPHY (SPECT)
    • 7.2.1. HYBRID SPECT SYSTEMS
    • 7.2.2. STANDALONE SPECT SYSTEMS
  • 7.3. HYBRID PET
  • 7.4. PLANAR SCINTIGRAPHY

8. NUCLEAR IMAGING EQUIPMENT MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. ONCOLOGY
  • 8.3. CARDIOLOGY
  • 8.4. NEUROLOGY
  • 8.5. OTHER APPLICATIONS

9. NUCLEAR IMAGING EQUIPMENT MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITALS
  • 9.3. IMAGING CENTERS
  • 9.4. ACADEMIC & RESEARCH CENTERS
  • 9.5. OTHER END USERS

10. NUCLEAR IMAGING EQUIPMENT MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
      • 10.2.1.1. Increase in adoption of nuclear imaging systems
      • 10.2.1.2. Decline in reimbursements for radiology
    • 10.2.2. CANADA
      • 10.2.2.1. Increase in adoption of PET imaging systems
  • 10.3. EUROPE
    • 10.3.1. EUROPE-5
      • 10.3.1.1. Increasing number of PET-CT procedures in the U.K.
      • 10.3.1.2. Increasing investments by stakeholders
      • 10.3.1.3. Installation of imaging systems in Spain
    • 10.3.2. RUSSIA
      • 10.3.2.1. Adoption of nuclear imaging equipment
    • 10.3.3. REST OF EUROPE
      • 10.3.3.1. Increased focus of market players
  • 10.4. ASIA-PACIFIC
    • 10.4.1. JAPAN
      • 10.4.1.1. Aging population and high healthcare expenditure
    • 10.4.2. CHINA
      • 10.4.2.1. Developing healthcare infrastructure
      • 10.4.2.2. Irregularities in the tendering process
    • 10.4.3. INDIA
      • 10.4.3.1. Increasing focus of global market players
      • 10.4.3.2. Increasing use of refurbished medical devices a major challenge for market players
    • 10.4.4. REST OF ASIA-PACIFIC (ROAPAC)
      • 10.4.4.1. Increasing public-private investments
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
    • 11.2.1. INTRODUCTION
    • 11.2.2. SIEMENS HEALTHCARE (GERMANY)
    • 11.2.3. GE HEALTHCARE (U.S.)
    • 11.2.4. PHILIPS HEALTHCARE (NETHERLANDS)
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. NEW PRODUCT LAUNCHES
    • 11.3.2. PARTNERSHIPS/COLLABORATIONS/ALLIANCES
    • 11.3.3. AGREEMENTS & CONTRACTS
    • 11.3.4. APPROVALS
    • 11.3.5. ACQUISITIONS
    • 11.3.6. OTHER STRATEGIES

12. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 12.1. INTRODUCTION
  • 12.2. SIEMENS AG (SIEMENS HEALTHINEERS)
  • 12.3. GE HEALTHCARE (A FULLY OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
  • 12.4. PHILIPS HEALTHCARE
  • 12.5. DIGIRAD CORPORATION
  • 12.6. NEUSOFT MEDICAL SYSTEMS CO., LTD.
  • 12.7. TOSHIBA MEDICAL SYSTEMS CORPORATION (ACQUIRED BY CANNON INC.)
  • 12.8. SURGICEYE GMBH
  • 12.9. DDD-DIAGNOSTIC A/S
  • 12.10. CMR NAVISCAN CORPORATION
  • 12.11. MEDISO MEDICAL IMAGING SYSTEMS LTD.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. OTHER DEVELOPMENTS
    • 13.2.1. SIEMENS HEALTHCARE
    • 13.2.2. GE HEALTHCARE
    • 13.2.3. PHILIPS HEALTHCARE
    • 13.2.4. DIGIRAD CORPORATION
    • 13.2.5. TOSHIBA MEDICAL SYSTEMS CORPORATION
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 2: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (UNITS)
  • TABLE 3: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 4: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 5: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (UNITS)
  • TABLE 6: HYBRID SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: STANDALONE SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: HYBRID PET IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: PLANAR SCINTIGRAPHY SYSTEMS/EQUIPMENT MARKET SIZE , BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 11: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 12: HYBRID PET IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 13: PLANAR SCINTIGRAPHY SYSTEMS/EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 14: NUCLEAR IMAGING EQUIPMENT MARKET SIZE FOR ONCOLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: NUCLEAR IMAGING EQUIPMENT MARKET SIZE FOR CARDIOLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: NUCLEAR IMAGING EQUIPMENT MARKET SIZE FOR NEUROLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: NUCLEAR IMAGING EQUIPMENT MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 19: NUCLEAR IMAGING EQUIPMENT MARKET SIZE FOR HOSPITALS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: NUCLEAR IMAGING EQUIPMENT MARKET SIZE FOR IMAGING CENTERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: NUCLEAR IMAGING EQUIPMENT MARKET SIZE FOR ACADEMIC & RESEARCH CENTERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: NUCLEAR IMAGING EQUIPMENT MARKET SIZE FOR OTHER END USERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 26: NORTH AMERICA: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 27: NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 28: NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 29: U.S.: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 30: U.S.: HYBRID PET IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 31: U.S.: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 32: U.S.: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 33: CANADA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 34: CANADA: HYBRID PET IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 35: CANADA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 36: CANADA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 37: EUROPE: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY REGION/COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: EUROPE: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 39: EUROPE: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 40: EUROPE: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 41: EUROPE: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 42: EUROPE-5: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 43: EUROPE-5: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 44: EUROPE-5: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 45: EUROPE-5: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 46: RUSSIA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 47: RUSSIA: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 48: RUSSIA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 49: RUSSIA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 50: ROE: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 51: ROE: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 52: ROE: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 53: ROE: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 54: ASIA-PACIFIC: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 55: ASIA-PACIFIC: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 56: ASIA-PACIFIC: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 57: ASIA-PACIFIC: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 58: ASIA-PACIFIC: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 59: JAPAN: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 60: JAPAN: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: JAPAN: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 62: JAPAN: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 63: CHINA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 64: CHINA: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: CHINA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 66: CHINA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 67: INDIA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 68: INDIA: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 69: INDIA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 70: INDIA: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 71: ROAPAC: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 72: ROAPAC: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: ROAPAC: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 74: ROAPAC: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 75: ROW: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 76: ROW: SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: ROW: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 78: ROW: NUCLEAR IMAGING EQUIPMENT MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 79: NEW PRODUCT LAUNCHES (2013-2016)
  • TABLE 80: PARTNERSHIPS/COLLABORATIONS/ALLIANCES (2013-2016)
  • TABLE 81: AGREEMENTS & CONTRACTS (2013-2016)
  • TABLE 82: APPROVALS (2013-2016)
  • TABLE 83: ACQUISITIONS (2013-2016)
  • TABLE 84: OTHER STRATEGIES (2013-2016)

LIST OF FIGURES

  • FIGURE 1: GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET SEGMENTATION
  • FIGURE 2: GLOBAL NUCLEAR IMAGING EQUIPMENT MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: RESEARCH DESIGN
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: SPECT SYSTEMS TO COMMAND THE LARGEST SHARE OF THE NUCLEAR IMAGING EQUIPMENT MARKET, BY PRODUCT, IN 2016
  • FIGURE 9: ONCOLOGY APPLICATION SEGMENT TO HOLD THE LARGEST SHARE OF THE MARKET, BY APPLICATION, IN 2016
  • FIGURE 10: HOSPITALS SEGMENT TO DOMINATE THE MARKET, BY END USER
  • FIGURE 11: ASIA-PACIFIC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 12: NUCLEAR IMAGING EQUIPMENT MARKET PROJECTED TO WITNESS A HIGH GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 13: ONCOLOGY APPLICATIONS SEGMENT TO DOMINATE THE MARKET IN 2016
  • FIGURE 14: ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 15: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: PORTER'S FIVE FORCES ANALYSIS: NUCLEAR IMAGING EQUIPMENT MARKET (2016)
  • FIGURE 17: SPECT SEGMENT IS EXPECTED TO DOMINATE THE NUCLEAR IMAGING EQUIPMENT MARKET IN 2016
  • FIGURE 18: ONCOLOGY SEGMENT IS EXPECTED TO DOMINATE THE NUCLEAR IMAGING EQUIPMENT MARKET IN 2016
  • FIGURE 19: HOSPITALS SEGMENT PROJECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE TOTAL NUCLEAR IMAGING EQUIPMENT MARKET
  • FIGURE 20: NUCLEAR IMAGING EQUIPMENT MARKET, BY REGION, 2016-2021 (USD MILLION)
  • FIGURE 21: SHARE OF GERIATRIC POPULATION IN THE TOTAL POPULATION, 2010 VS. 2030
  • FIGURE 22: NUMBER OF NEW CANCER CASES, BY COUNTRY, 2012 VS. 2020
  • FIGURE 23: NORTH AMERICA: NUCLEAR IMAGING EQUIPMENT MARKET SNAPSHOT
  • FIGURE 24: INCREASING PREVALENCE OF CANCER IS DRIVING THE MARKET GROWTH IN NORTH AMERICA
  • FIGURE 25: EUROPE: NUCLEAR IMAGING EQUIPMENT MARKET SNAPSHOT
  • FIGURE 26: EUROPE: NUMBER OF CANCER CASES REPORTED, BY COUNTRY
  • FIGURE 27: NUMBER OF NEW CANCER CASES, BY TYPE
  • FIGURE 28: ASIA-PACIFIC MARKET SNAPSHOT: CHINA, THE FASTEST-GROWING COUNTRY IN THE NUCLEAR IMAGING EQUIPMENT MARKET
  • FIGURE 29: ROW: NUCLEAR IMAGING EQUIPMENT MARKET SNAPSHOT
  • FIGURE 30: MAJOR DEVELOPMENTS, BY COMPANY, 2013-2016
  • FIGURE 31: NEW PRODUCT LAUNCHES-KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
  • FIGURE 32: NEW PRODUCT LAUNCHES, BY COMPANY (2013-2016)
  • FIGURE 33: PARTNERSHIPS/COLLABORATIONS/ALLIANCES, BY COMPANY (2013-2016)
  • FIGURE 34: AGREEMENTS & CONTRACTS, BY COMPANY (2013-2016)
  • FIGURE 35: APPROVALS, BY COMPANY (2013-2016)
  • FIGURE 36: ACQUISITIONS, BY COMPANY (2013-2016)
  • FIGURE 37: OTHER STRATEGIES, BY COMPANY (2013-2016)
  • FIGURE 38: GEOGRAPHIC REVENUE MIX OF THE TOP THREE MARKET PLAYERS
  • FIGURE 39: SIEMENS AG: COMPANY SNAPSHOT
  • FIGURE 40: GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 41: PHILIPS HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 42: DIGIRAD CORPORATION: COMPANY SNAPSHOT
  • FIGURE 43: NEUSOFT MEDICAL SYSTEMS CO., LTD.: COMPANY SNAPSHOT
Back to Top